These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6350722)

  • 1. Suppression and stimulation of mineralocorticoid hormones (MCH) in the simple virilizing form of congenital adrenal hyperplasia (CAH) evaluated by the quantitation in adrenal venous blood.
    Wajchenberg BL; Biglieri EG; Okada H; Malerbi DA; Achando SS; Kater CE
    J Steroid Biochem; 1983 Jul; 19(1B):655-61. PubMed ID: 6350722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oestrogen dynamics in adrenal venous effluents in congenital virilizing adrenal hyperplasia.
    Wajchenberg BL; Goldman J; Kyan TS; Achando SS; Thomsen YL; Lima SS
    Clin Endocrinol (Oxf); 1980 Oct; 13(4):401-4. PubMed ID: 7438482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired mineralocorticoid hormone responses to adrenocorticotropin stimulation: additional characterization of heterozygosity for the 21-hydroxylase deficiency type of congenital adrenal hyperplasia.
    Pardini DP; Kater CE; Vieira JG; Biglieri EG
    J Clin Endocrinol Metab; 1983 Nov; 57(5):1061-6. PubMed ID: 6311859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of continued adrenocorticotropin stimulation on the mineralocorticoid hormones in classical and nonclassical simple virilizing types of 21-hydroxylase deficiency.
    Kater CE; Biglieri EG; Wajchenberg B
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1057-62. PubMed ID: 2987285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etomidate: a selective adrenocortical 11 beta-hydroxylase inhibitor.
    Dörr HG; Kuhnle U; Holthausen H; Bidlingmaier F; Knorr D
    Klin Wochenschr; 1984 Nov; 62(21):1011-3. PubMed ID: 6096625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of several adrenal steroids to ACTH stimulation in essential hypertension.
    Honda M; Nowaczynski W; Guthrie GP; Messerli FH; Tolis G; Kuchel O; Genest J
    J Clin Endocrinol Metab; 1977 Feb; 44(2):264-72. PubMed ID: 190252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salt wasting in simple virilizing congenital adrenal hyperplasia.
    Frisch H; Battelino T; Schober E; Baumgartner-Parzer S; Nowotny P; Vierhapper H
    J Pediatr Endocrinol Metab; 2001; 14(9):1649-55. PubMed ID: 11795656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma 21-deoxycorticosterone (21-DB) levels in late-onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathway.
    Fiet J; Gueux B; Raux-DeMay MC; Kuttenn F; Vexiau P; Brerault JL; Couillin P; Galons H; Villette JM; Julien R
    J Clin Endocrinol Metab; 1989 Mar; 68(3):542-7. PubMed ID: 2537337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary-adrenal axis activity in treated congenital adrenal hyperplasia: static and dynamic studies.
    Pham-Huu-Trung MT; Gourmelen M; Raux-Eurin MC; Girard F
    J Clin Endocrinol Metab; 1978 Aug; 47(2):422-7. PubMed ID: 233672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary-adrenal responses to corticotropin-releasing hormone in different degrees of adrenal 21-hydroxylase deficiency.
    Moreira AC; Elias LL
    J Clin Endocrinol Metab; 1992 Jan; 74(1):198-203. PubMed ID: 1309366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenocortical steroid requirements for initiation of ACTH-dependent hypertension in sheep.
    Spence CD; Coghlan JP; Denton DA; Mills EH; Whitworth JA; Scoggins BA
    Clin Exp Pharmacol Physiol; 1989 Oct; 16(10):759-72. PubMed ID: 2558826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin and adrenal steroidogenesis: study of 21-hydroxylase-deficient congenital adrenal hyperplasia.
    Schaison G; Couzinet B; Gourmelen M; Elkik F; Bougneres P
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1390-4. PubMed ID: 7002950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of progesterone and some of its metabolites including deoxycorticosterone after oral and parenteral administration.
    Ottoson UB; Carlstrom K; Damber JE; von Schoultz B
    Br J Obstet Gynaecol; 1984 Nov; 91(11):1111-9. PubMed ID: 6498126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsalt-losing congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function.
    Pang S; Levine LS; Stoner E; Opitz JM; Pollack MS; Dupont B; New MI
    J Clin Endocrinol Metab; 1983 Apr; 56(4):808-18. PubMed ID: 6300166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial deficiency of adrenal 11-hydroxylase. A possible cause of primary hypertension.
    de Simone G; Tommaselli AP; Rossi R; Valentino R; Lauria R; Scopacasa F; Lombardi G
    Hypertension; 1985; 7(2):204-10. PubMed ID: 2984117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New studies of the 11 beta-hydroxylase and 18-hydroxylase enzymes in the hypertensive form of congenital adrenal hyperplasia.
    Levine LS; Rauh W; Gottesdiener K; Chow D; Gunczler P; Rapaport R; Pang S; Schneider B; New MI
    J Clin Endocrinol Metab; 1980 Feb; 50(2):258-63. PubMed ID: 6243663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the mineralocorticoid hormones in adrenocortical disorders with adrenocorticotropin excess.
    Kater CE; Biglieri EG; Brust N; Chang B; Hirai J
    Clin Exp Hypertens A; 1982; 4(9-10):1749-58. PubMed ID: 6291814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zona glomerulosa function after life-long suppression in two siblings with the hypertensive virilizing form of congenital adrenal hyperplasia.
    Rodríguez Portales JA; Arteaga E; López Moreno JM; Biglieri EG
    J Clin Endocrinol Metab; 1988 Feb; 66(2):349-54. PubMed ID: 3276723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoids in congenital adrenal hyperplasia.
    Biglieri EG; Kater CE
    J Steroid Biochem Mol Biol; 1991; 40(4-6):493-9. PubMed ID: 1958551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmented 17 alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas').
    Seppel T; Schlaghecke R
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):445-51. PubMed ID: 7955456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.